17,458 XNAS Volume
XNAS 17 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Takeo Mukai | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.21 per share. | 01 Mar 2024 | 8,475 | 72,874 | - | 0.2 | 1,780 | Form 4 |
| Sohn Tom | SVP, Gen. Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.17 per share. | 06 Feb 2024 | 7,582 | 105,009 | - | 0.2 | 1,312 | Form 4 |
| Mukai Takeo | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.19 per share. | 01 Feb 2024 | 2,869 | 81,349 | - | 0.2 | 548 | Form 4 |
| Tom Sohn | SVP, Gen. Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.19 per share. | 01 Feb 2024 | 5,709 | 112,591 | - | 0.2 | 1,090 | Form 4 |
| Mathews Kevin | SVP, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.19 per share. | 07 Jan 2024 | 6,342 | 61,106 | - | 0.2 | 1,199 | Form 4 |
| Roman H. David | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.19 per share. | 07 Jan 2024 | 24,086 | 332,134 | - | 0.2 | 4,552 | Form 4 |
| Kevin Mathews | SVP, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.69 per share. | 05 Aug 2023 | 134 | 67,448 | - | 0.7 | 92 | FORM 4 |
| Tom Sohn | SVP, Gen. Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.69 per share. | 05 Aug 2023 | 433 | 118,300 | - | 0.7 | 299 | FORM 4 |
| Takeo Mukai | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 02 Aug 2023 | 501 | 83,447 | - | 0 | FORM 4 | |
| Tom Sohn | SVP, Gen. Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 20,000 | 118,733 | - | 0 | FORM 4 | |
| David H. Roman | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Aug 2023 | 6,484 | 356,220 | - | 0 | FORM 4 | |
| John F. Sheridan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 8,400 | 24,347 | - | 0 | FORM 4 | |
| John F. Sheridan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 19,600 | 19,600 | - | - | FORM 4 | |
| R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 25,480 | 25,480 | - | - | FORM 4 | |
| R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,920 | 21,840 | - | 0 | FORM 4 | |
| David P. Bonita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 8,400 | 20,822 | - | 0 | FORM 4 | |
| David P. Bonita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 19,600 | 19,600 | - | - | FORM 4 | |
| Niamh Pellegrini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 19,600 | 19,600 | - | - | FORM 4 | |
| Niamh Pellegrini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 8,400 | 20,972 | - | 0 | FORM 4 | |
| Jason K. Garland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 8,400 | 22,400 | - | 0 | FORM 4 | |
| Jason K. Garland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 19,600 | 19,600 | - | - | FORM 4 | |
| Andrew ElBardissi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 19,600 | 19,600 | - | - | FORM 4 | |
| Andrew ElBardissi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 8,400 | 20,822 | - | 0 | FORM 4 | |
| Shaden Marzouk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 8,400 | 20,822 | - | 0 | FORM 4 | |
| Shaden Marzouk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 19,600 | 19,600 | - | - | FORM 4 | |
| David H. Roman | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.85 per share. | 01 Jun 2023 | 17,290 | 362,704 | - | 0.8 | 14,660 | FORM 4 |
| Kevin Mathews | SVP, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.75 per share. | 01 Apr 2023 | 321 | 66,332 | - | 0.8 | 242 | FORM 4 |
| Charlie Piscitello | SVP, Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.75 per share. | 01 Apr 2023 | 855 | 85,683 | - | 0.8 | 645 | FORM 4 |
| Tom Sohn | SVP, Gen. Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.75 per share. | 01 Apr 2023 | 855 | 98,733 | - | 0.8 | 645 | FORM 4 |
| David H. Roman | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.75 per share. | 01 Apr 2023 | 3,165 | 379,994 | - | 0.8 | 2,386 | FORM 4 |
| Kevin Mathews | SVP, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 42,500 | 66,653 | - | 0 | FORM 4 | |
| Kevin Mathews | SVP, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 42,500 | 42,500 | - | - | FORM 4 | |
| Charlie Piscitello | SVP, Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 42,500 | 86,538 | - | 0 | FORM 4 | |
| Charlie Piscitello | SVP, Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 42,500 | 42,500 | - | - | FORM 4 | |
| Tom Sohn | SVP, Gen. Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 42,500 | 42,500 | - | - | FORM 4 | |
| Tom Sohn | SVP, Gen. Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 42,500 | 99,588 | - | 0 | FORM 4 | |
| David H. Roman | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 135,000 | 383,159 | - | 0 | FORM 4 | |
| David H. Roman | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 135,000 | 135,000 | - | - | FORM 4 | |
| Takeo Mukai | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 47,500 | 47,500 | - | - | FORM 4 | |
| Takeo Mukai | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 47,500 | 83,948 | - | 0 | FORM 4 | |
| Kevin Mathews | SVP, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.87 per share. | 01 Feb 2023 | 3,540 | 24,153 | - | 1.9 | 6,620 | FORM 4 |
| Charlie Piscitello | SVP, Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.87 per share. | 01 Feb 2023 | 6,627 | 44,038 | - | 1.9 | 12,392 | FORM 4 |
| Tom Sohn | SVP, Gen. Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.87 per share. | 01 Feb 2023 | 6,525 | 57,190 | - | 1.9 | 12,202 | FORM 4 |
| David H. Roman | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.87 per share. | 01 Feb 2023 | 10,196 | 248,159 | - | 1.9 | 19,067 | FORM 4 |
| Takeo Mukai | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.87 per share. | 01 Feb 2023 | 2,855 | 36,448 | - | 1.9 | 5,339 | FORM 4 |
| R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 5,880 | 5,880 | - | - | Stock Options (Right to Buy) | |
| R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 2,520 | 10,920 | - | 0 | Common Stock | |
| Jason K. Garland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 32,500 | 32,500 | - | - | Stock Options (Right to Buy) | |
| Jason K. Garland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 14,000 | 14,000 | - | 0 | Common Stock | |
| Takeo Mukai | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 20,000 | 39,303 | - | 0 | Common Stock | |
| Kevin Mathews | SVP, Global Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.56 per share. | 05 Aug 2022 | 134 | 27,693 | - | 1.6 | 209 | Common Stock |
| Charlie Piscitello | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.56 per share. | 05 Aug 2022 | 433 | 49,415 | - | 1.6 | 675 | Common Stock |
| Tom Sohn | SVP, Gen. Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.56 per share. | 05 Aug 2022 | 433 | 63,613 | - | 1.6 | 675 | Common Stock |
| Kevin Mathews | SVP, Global Sales | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Jul 2022 | 21,583 | 35,467 | - | - | Employee Stock Options (Right to Buy) | |
| Kevin Mathews | SVP, Global Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 20,000 | 57,050 | - | - | Employee Stock Options (Right to Buy) | |
| Kevin Mathews | SVP, Global Sales | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Jul 2022 | 20,000 | 37,050 | - | - | Employee Stock Options (Right to Buy) | |
| Kevin Mathews | SVP, Global Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 15,647 | 57,050 | - | - | Employee Stock Options (Right to Buy) | |
| Kevin Mathews | SVP, Global Sales | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Jul 2022 | 15,467 | 41,583 | - | - | Employee Stock Options (Right to Buy) | |
| Kevin Mathews | SVP, Global Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 21,583 | 57,050 | - | - | Employee Stock Options (Right to Buy) | |
| Charlie Piscitello | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 51,418 | 146,740 | - | - | Employee Stock Options (Right to Buy) | |
| Charlie Piscitello | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Jul 2022 | 51,418 | 95,322 | - | - | Employee Stock Options (Right to Buy) | |
| Charlie Piscitello | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Jul 2022 | 28,022 | 118,718 | - | - | Employee Stock Options (Right to Buy) | |
| Charlie Piscitello | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 28,022 | 146,740 | - | - | Employee Stock Options (Right to Buy) | |
| Charlie Piscitello | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Jul 2022 | 34,800 | 111,940 | - | - | Employee Stock Options (Right to Buy) | |
| Charlie Piscitello | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 34,800 | 146,740 | - | - | Employee Stock Options (Right to Buy) | |
| Charlie Piscitello | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Jul 2022 | 32,500 | 114,240 | - | - | Employee Stock Options (Right to Buy) | |
| Charlie Piscitello | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 32,500 | 146,740 | - | - | Employee Stock Options (Right to Buy) | |
| Tom Sohn | SVP, Gen. Counsel & Secretary | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Jul 2022 | 28,022 | 107,934 | - | - | Employee Stock Options (Right to Buy) | |
| Tom Sohn | SVP, Gen. Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 41,134 | 135,956 | - | - | Employee Stock Options (Right to Buy) | |
| Tom Sohn | SVP, Gen. Counsel & Secretary | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Jul 2022 | 41,134 | 94,822 | - | - | Employee Stock Options (Right to Buy) | |
| Tom Sohn | SVP, Gen. Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 32,000 | 135,956 | - | - | Employee Stock Options (Right to Buy) | |
| Tom Sohn | SVP, Gen. Counsel & Secretary | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Jul 2022 | 32,000 | 103,956 | - | - | Employee Stock Options (Right to Buy) | |
| Tom Sohn | SVP, Gen. Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 34,800 | 135,956 | - | - | Employee Stock Options (Right to Buy) | |
| Tom Sohn | SVP, Gen. Counsel & Secretary | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Jul 2022 | 34,800 | 101,156 | - | - | Employee Stock Options (Right to Buy) | |
| Tom Sohn | SVP, Gen. Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 28,022 | 135,956 | - | - | Employee Stock Options (Right to Buy) | |
| David H. Roman | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Jul 2022 | 50,000 | 77,335 | - | - | Employee Stock Options (Right to Buy) | |
| David H. Roman | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 77,335 | 127,335 | - | - | Employee Stock Options (Right to Buy) | |
| David H. Roman | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Jul 2022 | 77,335 | 50,000 | - | - | Employee Stock Options (Right to Buy) | |
| David H. Roman | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 75,000 | 258,355 | - | 0 | Common Stock | |
| David H. Roman | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 50,000 | 127,335 | - | - | Employee Stock Options (Right to Buy) | |
| John F. Sheridan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,400 | 15,947 | - | 0 | Common Stock | |
| John F. Sheridan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 19,600 | 19,600 | - | - | Stock Options (Right to Buy) | |
| R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,400 | 8,400 | - | 0 | Common Stock | |
| R. Scott Huennekens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 19,600 | 19,600 | - | - | Stock Options (Right to Buy) | |
| David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 19,600 | 19,600 | - | - | Stock Options (Right to Buy) | |
| David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,400 | 12,422 | - | 0 | Common Stock | |
| Niamh Pellegrini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,400 | 12,572 | - | 0 | Common Stock | |
| Niamh Pellegrini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 19,600 | 19,600 | - | - | Stock Options (Right to Buy) | |
| Andrew ElBardissi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,400 | 12,422 | - | 0 | Common Stock | |
| Andrew ElBardissi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 19,600 | 19,600 | - | - | Stock Options (Right to Buy) | |
| Shaden Marzouk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 19,600 | 19,600 | - | - | Stock Options (Right to Buy) | |
| Shaden Marzouk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,400 | 12,422 | - | 0 | Common Stock | |
| David H. Roman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 100,000 | 183,355 | - | 0 | Common Stock | |
| Vincent J. Burgess | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share. | 01 Apr 2022 | 3,896 | 61,469 | - | 1.3 | 5,065 | Common Stock |
| Steven McQuillan | SVP, Clinical Affairs & QA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share. | 01 Apr 2022 | 733 | 45,844 | - | 1.3 | 953 | Common Stock |
| David H. Roman | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share. | 01 Apr 2022 | 3,248 | 83,355 | - | 1.3 | 4,222 | Common Stock |
| Steven McQuillan | SVP, Clinical Affairs & QA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 32,000 | 46,577 | - | 0 | Common Stock | |
| Steven McQuillan | SVP, Clinical Affairs & QA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 32,000 | 32,000 | - | - | Stock Options (Right to Buy) | |
| David H. Roman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 50,000 | 86,603 | - | 0 | Common Stock | |
| David H. Roman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 50,000 | 50,000 | - | - | Stock Options (Right to Buy) | |
| Niamh Pellegrini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 15,191 | 15,191 | - | - | Stock Options (Right to Buy) | |
| Niamh Pellegrini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2021 | 4,172 | 4,172 | - | 0 | Common Stock | |
| Vincent J. Burgess | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.52 per share. | 05 Aug 2021 | 1,922 | 65,365 | - | 15.5 | 29,829 | Common Stock |
| Steven McQuillan | SVP, Clinical Affairs & QA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.52 per share. | 05 Aug 2021 | 305 | 14,577 | - | 15.5 | 4,734 | Common Stock |
| David P. Bonita | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.00 per share. | 19 Jul 2021 | 714,285 | 4,872,025 | - | 14 | 9,999,990 | Common Stock |
| David P. Bonita | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.00 per share. | 19 Jul 2021 | 357,143 | 1,677,361 | - | 14 | 5,000,002 | Common Stock |
| Shahzad Malik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 7,022 | 7,022 | - | - | Stock Options (Right to Buy) | |
| Shahzad Malik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 1,800 | 4,022 | - | 0 | Common Stock | |
| David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 1,800 | 4,022 | - | 0 | Common Stock | |
| David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 7,022 | 7,022 | - | - | Stock Options (Right to Buy) | |
| Andrew ElBardissi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 1,800 | 4,022 | - | 0 | Common Stock | |
| Andrew ElBardissi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 7,022 | 7,022 | - | - | Stock Options (Right to Buy) | |
| Shaden Marzouk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 7,022 | 7,022 | - | - | Stock Options (Right to Buy) | |
| Shaden Marzouk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 1,800 | 4,022 | - | 0 | Common Stock | |
| Vincent J. Burgess | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 158,691 | 158,691 | - | - | Stock Options (Right to Buy) | |
| Vincent J. Burgess | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 45,065 | 67,287 | - | 0 | Common Stock | |
| Steven McQuillan | SVP, Clinical Affairs & QA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 9,882 | 14,882 | - | 0 | Common Stock | |
| Steven McQuillan | SVP, Clinical Affairs & QA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 34,800 | 34,800 | - | - | Stock Options (Right to Buy) | |
| David H. Roman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 36,603 | 36,603 | - | 0 | Common Stock | |
| David H. Roman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 77,335 | 77,335 | - | - | Stock Options (Right to Buy) | |
| John F. Sheridan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2021 | 3,147 | 7,547 | - | 0 | Common Stock | |
| John F. Sheridan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2021 | 10,882 | 10,882 | - | - | Stock Options (Right to Buy) | |
| Shahzad Malik | None | 10 Aug 2020 | 171,695 | 0 | - | - | Series D Convertible Preferred Stock | ||
| Shahzad Malik | None | 10 Aug 2020 | 34,261 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Shahzad Malik | None | 10 Aug 2020 | 254,495 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Shahzad Malik | None | 10 Aug 2020 | 10,738 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Shahzad Malik | None | 10 Aug 2020 | 1,551,713 | 1,551,713 | - | 0 | Common Stock | ||
| Shahzad Malik | None | 10 Aug 2020 | 65,436 | 65,436 | - | 0 | Common Stock | ||
| Shahzad Malik | None | 10 Aug 2020 | 812,683 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Shahzad Malik | None | 10 Aug 2020 | 13,195 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Shahzad Malik | None | 10 Aug 2020 | 312,840 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Shahzad Malik | None | 10 Aug 2020 | 7,242 | 0 | - | - | Series D Convertible Preferred Stock | ||
| David P. Bonita | Director, Ten Percent Owner | 10 Aug 2020 | 3,784,240 | 4,157,740 | - | 0 | Common Stock | ||
| David P. Bonita | Director, Ten Percent Owner | 10 Aug 2020 | 378,733 | 0 | - | - | Series D Convertible Preferred Stock | ||
| David P. Bonita | Director, Ten Percent Owner | 10 Aug 2020 | 1,202,117 | 0 | - | - | Series D Convertible Preferred Stock | ||
| David P. Bonita | Director, Ten Percent Owner | 10 Aug 2020 | 389,116 | 0 | - | - | Series D Convertible Preferred Stock | ||
| David P. Bonita | Director, Ten Percent Owner | 10 Aug 2020 | 899,985 | 0 | - | - | Series C Convertible Preferred Stock | ||
| David P. Bonita | Director, Ten Percent Owner | 10 Aug 2020 | 647,582 | 0 | - | - | Series C Convertible Preferred Stock | ||
| David P. Bonita | Director, Ten Percent Owner | 10 Aug 2020 | 673,123 | 0 | - | - | Series B Convertible Preferred Stock | ||
| David P. Bonita | Director, Ten Percent Owner | 10 Aug 2020 | 872,302 | 0 | - | - | Series B Convertible Preferred Stock | ||
| David P. Bonita | Director, Ten Percent Owner | 10 Aug 2020 | 1,278,718 | 1,320,218 | - | 0 | Common Stock | ||
| David P. Bonita | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 10 Aug 2020 | 41,500 | 41,500 | - | 18 | 747,000 | Common Stock |
| David P. Bonita | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 10 Aug 2020 | 373,500 | 373,500 | - | 18 | 6,723,000 | Common Stock |
| John Barnickel | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 10 Aug 2020 | 7,300 | 13,966 | - | 18 | 131,400 | Common Stock |
| Vincent J. Burgess | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 22,222 | 22,222 | - | 0 | Common Stock | |
| Vincent J. Burgess | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 124,542 | 124,542 | - | - | Stock Options (Right to Buy) | |
| Shahzad Malik | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 2,222 | 2,222 | - | 0 | Common Stock | |
| Shahzad Malik | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 12,454 | 12,454 | - | - | Stock Options (Right to Buy) | |
| David P. Bonita | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 2,222 | 2,222 | - | 0 | Common Stock | |
| David P. Bonita | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 12,454 | 12,454 | - | - | Stock Options (Right to Buy) | |
| Gary W. Doherty | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 28,022 | 28,022 | - | - | Stock Options (Right to Buy) | |
| Gary W. Doherty | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 5,000 | 5,000 | - | 0 | Common Stock | |
| John Barnickel | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 6,666 | 6,666 | - | 0 | Common Stock | |
| John Barnickel | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 153,569 | 153,569 | - | - | Stock Options (Right to Buy) | |
| Andrew ElBardissi | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 2,222 | 2,222 | - | 0 | Common Stock | |
| Andrew ElBardissi | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 12,454 | 12,454 | - | - | Stock Options (Right to Buy) | |
| Shaden Marzouk | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 2,222 | 2,222 | - | 0 | Common Stock | |
| Shaden Marzouk | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 12,454 | 12,454 | - | - | Stock Options (Right to Buy) |